• Cellebrite DI Ltd CLBT.OQ reported quarterly adjusted earnings of 10 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 8 cents. The mean expectation of eight analysts for the quarter was for earnings of 8 cents per share. Wall Street expected results to range from 7 cents to 10 cents per share.

• Revenue rose 20.1% to $107.55 million from a year ago; analysts expected $109.36 million.

• Cellebrite DI Ltd's reported EPS for the quarter was 7 cents​.

• The company reported quarterly net income of $17.4 million.

• Cellebrite DI Ltd shares had risen by 3.6% this quarter and lost 8.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 10.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the software peer group is also "buy"

• Wall Street's median 12-month price target for Cellebrite DI Ltd is $27.50

This summary was machine generated from LSEG data May 14 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)